Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain
14 juin 2023 06h00 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Nasal Drug Delivery Technology Market was valued at US$71.0 billion in 2022 and is projected to grow at a CAGR of 7.5% during the forecast period 2023-2033. ...
Menopause Market is projected to grow at a CAGR of 5.4% by 2033: Visiongain
23 mai 2023 06h53 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Menopause Market was valued at US$17.33 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033. Visiongain has...
Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain Reports Ltd
04 mai 2023 12h22 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...
Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain Reports Ltd
19 avr. 2023 11h58 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...
Gynaecology Drugs market is projected to grow at a CAGR of 5.1% by 2033: Visiongain Reports Ltd
13 avr. 2023 06h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...
Gynaecology Drugs market is projected to grow at a CAGR of 5.1% by 2033: Visiongain Reports Ltd
15 mars 2023 10h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...
Meningococcal vaccines market is projected to grow at a CAGR of 6.32% by 2033: Visiongain Reports Ltd
28 févr. 2023 09h20 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Meningococcal Vaccines 2023-2033. It includes profiles of Meningococcal Vaccines and Forecasts Market Segment by Vaccine Type (Conjugate,...
Gynaecology Drugs market is projected to grow at a CAGR of 5.1% by 2033: Visiongain Reports Ltd
13 févr. 2023 11h13 HE
|
Visiongain Reports Ltd
Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...
Global mRNA Vaccines & Therapeutics market is projected to decline at a CAGR of -7.89% by 2032: Visiongain Reports Ltd
30 août 2022 07h26 HE
|
Visiongain Reports Ltd
Market Segment by Type (mRNA Prophylactic Vaccines, Therapeutics Vaccines, mRNA Therapeutics), Market Segment by Vector (Self-amplifying, Non-amplifying mRNA), Market Segment by Vector Platforms...
Global Rare Disease Market Research Report Up to 2031: Visiongain Research Inc
13 avr. 2022 11h00 HE
|
Visiongain Ltd
Visiongain has published a new report on “Rare Disease Market Forecast 2021-2031: By Drugs (Revlimid, MabThera/Rituxan, Opdivo, Imbruvica, Sprycel, Tasigna, Copaxone,Rebif, Gleevec, Velcade, Others),...